NCT07514793 2026-04-07Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced MesotheliomaFudan UniversityPhase 2 Not yet recruiting37 enrolled
NCT07420010 2026-02-19An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.Zhejiang UniversityPhase EARLY_PHASE1 Not yet recruiting24 enrolled